Get started
Author

Айнур Фанутович Насретдинов

Observed names: A F Nasretdinov, A. F. Nasretdinov, A. Nasretdinov, A.F. Nasretdinov, A.F. Nasretdinov Nasretdinov, A.  F. Nasretdinov, A.   F. Nasretdinov, AF Nasretdinov, Ainur F. Nasretdinov, Ainur Nasretdinov, А. Ф. Насретдинов, А.Ф. Насретдинов, Насретдинов А. Ф., Насретдинов А.Ф., Насретдинов Айнур Фанутович, Насретдинов, А.Ф.
ORCID: 0000-0001-8340-7962
Observed ORCID: 0000-0001-8340-7962
OpenAlex ID: A5009005144
Mechanisms of Formation of Specific Antitumor Immunity and Resistance to Immune Checkpoint Inhibitors
2024 · Александр Валерьевич Султанбаев, Ирина Александровна Тузанкина, et al. · Voprosy Onkologii · 7
Neuroendocrine Tumours: a Literature Review
2021 · K. V. Menshikov, A. V. Sultanbaev, et al. · Creative Surgery and Oncology · 6
PDF
Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer
2020 · A. F. Nasretdinov, N. I. Sultanbaeva, et al. · Tumors of female reproductive system · 6
PDF
Hereditary prostate cancer screening
2020 · A. Sultanbaev, A. Nasretdinov, et al. · European Urology Open Science · 4
Organization of screening for prostate cancer in carriers of germinal mutations in the BRCA1 / 2 genes
2020 · A. Sultanbaev, K. Menshikov, et al. · European Urology Open Science · 4
25P Identification of gene mutations in patients with breast cancer in a region located in the southeast of the European part of Russia
2020 · A. Sultanbaev, I. Minniakhmetov, et al. · Annals of Oncology · 4
Spectrum and frequency of BRCA1, BRCA2, CHEK2, PALB2, RAD50 mutations in breast cancer patients in the Republic of Bashkortostan
2020 · A V Pushkarev, N I Sultanbaeva, et al. · Kazan medical journal · 4
12P EGFR gene mutations landscape at lung cancer in a multinational region located in the southeast of the European part of Russia
2020 · A. Sultanbaev, A. Nasretdinov, et al. · Annals of Oncology · 4
PDF
Palbociclib in real clinical practice: Results of a single-center observational study
2024 · A. V. Sultanbaev, I. V. Kolyadina, et al. · Meditsinskiy sovet = Medical Council · 3
PDF
The Role of Chromosomal V(d)j Recombination of Lymphocytes in the Formation of Antitumor Immunity and the Effectiveness of Immunotherapy
2023 · A. Sultanbaev, Sh. Musin, et al. · Molekulyarnaya Meditsina (Molecular medicine) · 3
Inhibitors of cyclin-dependent kinases 4/6 for breast cancer patients with different somatic mutations of the PIK3CA gene
2020 · A. F. Nasretdinov, N. I. Sultanbaeva, et al. · Meditsinskiy sovet = Medical Council · 3
PDF
Efficacy and safety of alpelisib in patients with HR+HER2-negative metastatic breast cancer in real clinical practice: Results of a single-center observational retrospective study
2024 · Alexander V. Sultanbaev, Irina V. Kolyadina, et al. · Journal of Modern Oncology · 2
PDF
Breast cancer screening in germline mutation carriers. A literature review
2023 · A. V. Sultanbaev, A. F. Nasretdinov, et al. · Tumors of female reproductive system · 2
PDF
58P Quantitative indicators of TREC and KREC excision rings in breast cancer
2023 · A.V. Sultanbaev, S. Musin, et al. · ESMO Open · 2
PDF
The mechanism of action of different generations of EGFR-inhibitors in malignant lung tumors. Literature review and data synthesis
2022 · Ainur F. Nasretdinov, Konstantin V. Menshikov, et al. · Journal of Modern Oncology · 2
PDF
70P Local features of germinal mutations incidence in cancer patients in the Republic of Bashkortostan
2021 · A.V. Sultanbaev, K. Menshikov, et al. · Annals of Oncology · 2
PDF
Germinal mutations landscape, which is responsible for cancer predisposition in multinational Republic of Bashkortostan.
2021 · Alexnder Valerievich Sultanbaev, Oleg Lipatov, et al. · Journal of Clinical Oncology · 2
Treatment of advanced small cell lung cancer. Clinical case and literature review
2021 · Konstantin V. Menshikov, Aleksandr V. Sultanbaev, et al. · Journal of Modern Oncology · 2
PDF
Efficacy and safety of lenvatinib and everolimus combination in patients with metastatic renal cell carcinoma progression following targeted antiangiogenic therapy: secondary analysis of data obtained in the Russian multicenter observational study
2021 · M. I. Volkova, A. S. Kalpinskiy, et al. · Cancer Urology · 2
PDF
Results of the use of immune checkpoint inhibitors in the treatment of small cell lung cancer in real-life clinical practice: results of a single-center observational study
2025 · A.V. Sultanbaev, I.A. Tuzankina, et al. · P A Herzen Journal of Oncology · 1
193P Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice: Experience of re-challenge mode of olaparib usage
2022 · A.V. Sultanbaev, K. Menshikov, et al. · Annals of Oncology · 1
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study
2022 · Alexander V. Sultanbaev, Konstantin V. Menshikov, et al. · Journal of Modern Oncology · 1
PDF
Territorial manifestation features of multiple primary malignant neoplasms in carriers of germline mutations in the BRCA 1 gene in Republic of Bashkortostan.
2022 · Alexnder Valerievich Sultanbaev, Konstantin Menshikov, et al. · Journal of Clinical Oncology · 1
Abstract P1-07-09: Results of treatment with inhibitors of cycline-dependent kinase CDK4/6 in patients with breast cancer in the presence of different types mutation in the PIK3CA gene
2022 · Alexander Sultanbaev, Ainur Nasretdinov, et al. · Cancer Research · 1
Surgical stage in sequential therapy of unresectable oral cancer T3-4bN0-3M0: evaluation of treatment results
2021 · Sh. I. Musin, A. V. Sultanbayev, et al. · Head and neck tumors (HNT) · 1
PDF
Works count: 98
Citation count: 74
H-index: 4
I10-index:
Year
Topic
Type